Cellectricon AB, a collaborative research organization dedicated to advancing drug discovery and research in the areas of chronic pain and CNS diseases, today announced the launch of a novel assay platform for in vitro neurodegenerative disease research. The platform, based on a patent-pending microfluidics technology, has been developed over the ... Read More...
Recent Posts
- Medical Director of Plena Global Holdings Speaking at CannaWorld Congress November 22, 2018
- Thames Valley Triathletes Hold Their Third Triathlon In Iconic Beale Park, Berkshire November 2, 2018
- London premiere of new documentary “Women: A Success Story,” celebrates equality November 1, 2018
- Will your business development falter due to digital disruption? Not with BearingPoint//Beyond’s solution October 25, 2018
- New opportunity for discovery of highly differentiated therapeutics for Alzheimer’s & Parkinson’s diseases announced October 24, 2018
Submit Your Press Release at eNewsWire
eNewsWire is an online press release service offering both free and paid distribution. eNewWire distributes business, organisational and personal news and press releases using the Internet. Submit your press release here.